Domains

Across disease status

How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.

5 groups · up to 5993 samples · 35 datasets

Group	Median	Samples
Healthy/control	730.5200-2,469	456
Non-cancer disease	487241-1,592	201
Metastatic cancer	467170-1,024	339
Unresolved	46377.5-1,064	21
Primary cancer	369173-775	5,993

Across organs

How the same metric changes across tissue contexts after the current filters and tier are applied.

8 groups · up to 486 samples · 6 datasets

Group	Median	Samples
Musculoskeletal	5,9183,791-7,586	1
Small intestine	4,8382,228-8,193	18
Bone marrow	3,934831.5-7,636	48
Kidney	3,9161,884-7,050	20
Adrenal gland	3,2171,466-6,402	16
Heart	3,1491,496-3,832	1
Liver	1,697616-3,794	486
Spinal cord	1,193498-2,004	48

Disease status x organ

The combined comparison, useful for separating disease effects from tissue composition.

10 groups · up to 32 samples · 3 datasets

Group	Median	Samples
Healthy/control x Musculoskeletal	5,9183,791-7,586	1
Non-cancer disease x Brain	5,7481,084-7,640	1
Healthy/control x Small intestine	4,8382,228-8,193	18
Primary cancer x Bone marrow	4,5681,629-7,843	32
Non-cancer disease x Kidney	3,9161,884-7,050	20
Healthy/control x Pancreas	3,9063,447-4,331	2
Primary cancer x Adrenal gland	3,2171,466-6,402	16
Healthy/control x Heart	3,1491,496-3,832	1
Healthy/control x Brain	3,1051,495-4,386	3
Non-cancer disease x Skin	2,6761,629-5,940	2